Concepedia

Barbara A. Helfrich

BA

Statistics

Publications

25

Citations

2.8K

H-Index

22

Active since

1989

Affiliations

University of Colorado Denver(Current)

University of Colorado Cancer Center

University of Colorado Health

University of Colorado Anschutz Medical Campus

Immunovaccine (Canada)

Barbara A. Helfrich is an author at University of Colorado Denver specializing in oncology, medicine, and pharmacology.

Publications per year

1989–2016

25

Publications

25

Restoring E-Cadherin Expression Increases Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cell Lines

Samir E. Witta, Robert M. Gemmill, Fred R. Hirsch et al. · Cancer Research · 2006 · 532 citations · Full text

, , +17

Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non–small cell lung carcinoma

Barbara Frederick, Barbara A. Helfrich, Christopher D. Coldren et al. · Molecular Cancer Therapeutics · 2007 · 273 citations

, , +17

Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer Cells

Lindsay A. Marek, Kathryn E. Ware, Alexa Fritzsche et al. · Molecular Pharmacology · 2008 · 226 citations · Full text

, , +17

Altered HOX and WNT7A expression in human lung cancer

Roser Calvo, James West, Wilbur A. Franklin et al. · Proceedings of the National Academy of Sciences · 2000 · 188 citations

, , +13

ZEB1-responsive genes in non-small cell lung cancer

Robert M. Gemmill, Joëlle Roche, Vincent Potiron et al. · Cancer Letters · 2010 · 181 citations

, , +12

1–5 of 25